Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
The resourcefulness of the industry is clearly evident in the number of product approvals and products that are in late stages of clinical development. Two-thirds of these products are being developed to meet the needs of patient and physicians in diseases that represent underserved or unmet medica...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
